Professor Helen Marshall

Affiliate Lecturer, Medical Director VIRTU & A-Prof Vaccinology

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Professor Marshall is a medical researcher with specialist training in child health, public health and vaccinology, having completed a Bachelor of Medicine and Surgery, Doctorate of Medicine, Master in Public Health and Diploma in Child Health at the University of Adelaide and completed the international Advanced Vaccinology Course at the Pasteur Merieux Institute, France. She holds the positions of Professor in Vaccinology in the Adelaide Medical School, and Deputy Director, Clinical and Translational Research for the Robinson Research Institute at The University of Adelaide. Prof Marshall also holds the position of Senior Medical Practitioner and Medical Director, Vaccinology and Immunology Research Trials Unit (VIRTU), in the Department of Paediatrics at the Women’s and Children’s Hospital. She was awarded a NHMRC Career Development Fellowship (CDF) in 2011, a NHMRC CDF(2) in 2015 and NHMRC Practitioner Fellowship 2019-2023.

In recognition of Prof. Marshall's research leadership, she was awarded the South Australia Science Award for Excellence in Research Collaboration in 2019, Research for the Public Good in 2010, and a national Public Health Association of Australia Fellowship in 2013. Her research was included in the NHMRC “10 of the best” research projects for 2016. She was the recipient of the Australia Day Council, Inspiring South Australian Women Award in 2020.

Professor Marshall’s research program is directed to address urgent priorities in infectious disease prevention in children and includes implementation research and clinical trials in investigational and licensed vaccines, infectious and social epidemiology and public health. Her main interests include meningococcal, human papillomavirus, influenza and pertussis infections and their prevention by immunisation. Professor Marshall has been an investigator on 108 implementation, clinical and epidemiological studies. Professor Marshall’s research group, VIRTU, is the only research centre in Australia using social science research methodologies to investigate community attitudes to the introduction of new vaccines.

Since 2004, Prof. Marshall has published over 200 peer-reviewed papers in high quality general medicine and specialist journals across diverse disciplines with individual paper citations > 400. Her h-index = 44 and i10-index is 135. She has been awarded 17 NHMRC (CIA x 5, including 3 Fellowships), ARC, Government, Foundation and Industry grants totaling >$33 million. Her leadership is recognized by 41 international and 32 national invited speaker invitations.

My Research
Career
Publications
Grants and Funding
Teaching
Supervision
Professional Activities
Contact

Available Research Projects

The research program at the Vaccinology and Immunology Research Trials Unit (VIRTU) is directed to address urgent priorities
in infectious disease prevention and includes clinical trials in investigational vaccines, infectious and social epidemiology and public health. VIRTU conducts ongoing research on meningococcal, influenza, pneumococcal and pertussis vaccines and suitable HDR projects within these broad areas can be developed after discussion with Prof. Helen Marshall, Director of the Unit. One of the main areas of current research at VIRTU includes meningococcal disease.
Meningococcal disease causes significant morbidity and mortality worldwide and invasive meningococcal disease can result in long-term disability. VIRTU currently conducts several projects on meningococcal disease including the following:

The “B Part of It study, the largest study of its kind globally assessing the herd immunity impact of meningococcal B vaccine.
Assessing long-term physical, neurocognitive, economic and societal impact of invasive meningococcal disease in Australian adolescents and young adults
Evaluation of the newly implemented South Australian immunisation program against meningococcal B disease

In addition to projects suitable for HDR students, VIRTU routinely conducts systematic reviews and meta-analyses on infectious diseases and vaccines which are suitable for third year undergraduate research students.

My Research

Appointments

Date	Position	Institution name
2015 - ongoing	Deputy Director, Clinical and Translational Research, Robinson Research Institute	University of Adelaide
2014 - ongoing	Professor in Vaccinology, Discipline of Paediatrics	University of Adelaide
2013 - ongoing	Research Leader, Child and Adolescent Health, Robinson Research Institute	University of Adelaide
2011 - ongoing	National Health Medical Research Council Practitioner Fellow, Adelaide Medical School	University of Adelaide
1998 - ongoing	Senior Medical Practitioner and Medical Director, Vaccinology and Immunology Research Trials Unit, VIRTU	Women's and Children's Health Network

Awards and Achievements

Date	Type	Title	Institution Name	Country
2020	Award	Inspiring South Australian Women Award	Australia Day Council	Australia
2019	Award	SA Science Excellence and Innovation Awards - Excellence in Research Collaboration	Department for Innovation and Skills, Government of South Australia	Australia
2017	Achievement	10 of the Best NHMRC Research Projects	National Health and Medical Research Council	Australia
2016	Award	Alice Davey Award	Faculty of Health and Medical Sciences, University of Adelaide	Australia
2015	Award	Women’s Research Excellence Award	University of Adelaide	Australia
2013	Fellowship	Fellowship in recognition of contribution to public health	National Public Health Association of Australia	Australia
2010	Award	SA Science Excellence and Innovation Awards - Excellence in Research for the Public Good	Department for Innovation and Skills, Government of South Australia	Australia

Education

Date Institution name Country Title

2011 University of Adelaide Australia MD

2004 University of Adelaide Australia MPH

1988 University of Adelaide Australia MBBS
Postgraduate Training

Date Title Institution Country

1999 Diploma in Child Health Women's and Children's Hospital and University of Adelaide Australia
Research Interests

Child and Adolescent Health Immunology and Infection Translational Health Outcomes

Date	Institution name	Country	Title
2011	University of Adelaide	Australia	MD
2004	University of Adelaide	Australia	MPH
1988	University of Adelaide	Australia	MBBS

Date	Title	Institution	Country
1999	Diploma in Child Health	Women's and Children's Hospital and University of Adelaide	Australia

Journals

Year	Citation
2022	Stevens, N. E., van Wolfswinkel, M., Bao, W., Ryan, F. J., Brook, B., Amenyogbe, N., . . . Lynn, D. J. (2022). Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice. Vaccine, 40(11), 1594-1605. DOI Scopus3 WoS3 Europe PMC1
2022	McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., Bednarz, J., MacLennan, J. M., . . . Marshall, H. S. (2022). 'B Part of It' School Leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (4CMenB) vaccine on carriage of Neisseria meningitidis. Journal of Infectious Diseases, 225(4), 637-649. DOI
2022	Norman, D. A., Cheng, A. C., Macartney, K. K., Moore, H. C., Danchin, M., Seale, H., . . . Blyth, C. C. (2022). Influenza hospitalizations in Australian children 2010-2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness. Influenza and Other Respiratory Viruses, 16(2), 316-327. DOI Europe PMC1
2022	Quinn, H. E., Comeau, J. L., Marshall, H. S., Elliott, E. J., Crawford, N. W., Blyth, C. C., . . . Wood, N. J. (2022). Pertussis disease and antenatal vaccine effectiveness in Australian children. The Pediatric Infectious Disease Journal, 41(3), 180-185. DOI
2022	McMillan, M., Marshall, H. S., & Richmond, P. (2022). 4CMenB vaccine and its role in preventing transmission and inducing herd immunity. Expert Review of Vaccines, 21(1), 103-114. DOI
2022	Rahaman, M. R., Burgess, T., Marshall, H., Milazzo, A., Chaber, A. -L., Crabb, D., & Bi, P. (2022). Q fever prevention: perspectives from university animal science and veterinary students and livestock farmers. Australian Journal of Rural Health, [1]-[8]. DOI
2022	Chang, A. B., Toombs, M., Chatfield, M. D., Mitchell, R., Fong, S. M., Binks, M. J., . . . Grimwood, K. (2022). Study protocol for preventing early-onset pneumonia in young children through maternal immunisation: a multi-centre randomised controlled trial (PneuMatters). Frontiers in Pediatrics, 9, 781168-1-781168-12. DOI
2022	Tuckerman, J., Harper, K., Sullivan, T. R., Fereday, J., Couper, J., Smith, N., . . . Marshall, H. (2022). Using provider-parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol. BMJ Open, 12(2), 7 pages. DOI
2022	Marshall, H. S., Andraweera, P. H., Ward, J., Kaldor, J., Andrews, R., Macartney, K., . . . Whop, L. (2022). An observational study to assess the effectiveness of 4CMenB against meningococcal disease and carriage and gonorrhea in adolescents in the Northern Territory, Australia—study protocol. Vaccines, 10(2), 309-1-309-13. DOI
2022	Begum, H., Dwyer, D. E., Holmes, M., Irving, L., Simpson, G., Senenayake, S., . . . Cheng, A. (2022). Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN). Communicable diseases intelligence (2018), 46. DOI
2022	Wang, B., Giles, L., Andraweera, P., McMillan, M., Almond, S., Beazley, R., . . . Marshall, H. (2022). Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. . The Lancet. Infectious diseases, S1473-3099(21)00754-4. DOI
2022	Cheng, A. C., Dwyer, D. E., Holmes, M., Irving, L., Simpson, G., Senenayake, S., . . . Kelly, P. (2022). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). Communicable diseases intelligence (2018), 46. DOI
2022	Clarke, M., Mathew, S. M., Giles, L. C., Pena, A. S., Barr, I. G., Richmond, P. C., & Marshall, H. S. (2022). A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents. Vaccines, 10(5), 699. DOI
2021	Rahaman, M., Milazzo, A., Marshall, H., Chaber, A. -L., & Bi, P. (2021). Q fever vaccination: Australian animal science and veterinary students’ One Health perspectives on Q fever prevention. Human Vaccines and Immunotherapeutics, 17(5), 1374-1381. DOI Scopus1 WoS1
2021	Burrell, R., Jones, C. A., Britton, P. N., Dale, R. C., Blyth, C. C., Clark, J. E., . . . Francis, J. (2021). Altered Behavior in Encephalitis: Insights From the Australian Childhood Encephalitis Study, 2013–2018. Frontiers in Pediatrics, 9. DOI
2021	Wurzel, D., McMinn, A., Hoq, M., Blyth, C. C., Burgner, D., Tosif, S., . . . Crawford, N. W. (2021). Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study. BMJ Open, 11(11), e054510-1-e054510-9. DOI Scopus2 WoS2 Europe PMC1
2021	Marshall, H. S. (2021). Meningococcal surveillance in Southeast Asia and the Pacific. Microbiology Australia, 42(4), 178-181. DOI
2021	Wang, B., Nolan, R., & Marshall, H. (2021). Covid-19 immunisation, willingness to be vaccinated and vaccination strategies to improve vaccine uptake in Australia. Vaccines, 9(12), 1467. DOI Scopus1 WoS1 Europe PMC1
2021	Rahaman, M. R., Hodgetts, K., Milazzo, A., Marshall, H., Chaber, A. -L., Crabb, D., & Bi, P. (2021). Q fever prevention in Australia: general practitioner and stakeholder perspectives on preparedness and the potential of a One Health approach.. Aust N Z J Public Health, 46(2), 196-202. DOI
2021	Martinón-Torres, F., Banzhoff, A., Azzari, C., de Wals, P., Marlow, R., Marshall, H., . . . Bekkat-Berkani, R. (2021). Recent advances in the prevention of meningococcal B disease: real evidence from 4CMenB vaccination. Vacunas, 22(3), 189-202. DOI
2021	Mohammed, H., McMillan, M., Andraweera, P. H., Elliott, S. R., & Marshall, H. S. (2021). A rapid global review of strategies to improve influenza vaccination uptake in Australia. Human Vaccines and Immunotherapeutics, 17(12), 5487-5499. DOI
2021	Whelan, J., Marshall, H., & Sullivan, T. R. (2021). Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics. PloS one, 16(10), 1-9. DOI
2021	Davies, C., Marshall, H. S., Zimet, G., McCaffery, K., Brotherton, J. M. L., Kang, M., . . . Skinner, S. R. (2021). Effect of a school-based educational intervention about the human papillomavirus vaccine on psychosocial outcomes among adolescents: analysis of secondary outcomes of a cluster randomized trial. JAMA Network Open, 4(11), e2129057-1-e2129057-15. DOI Scopus1 WoS1
2021	Martinón-Torres, F., Banzhoff, A., Azzari, C., De Wals, P., Marlow, R., Marshall, H., . . . Berkani, R. B. (2021). Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination: Real-world effectiveness of MenB vaccination.. The Journal of infection, 83(1), 17-26. DOI Scopus6 WoS5 Europe PMC4
2021	Norman, D. A., Carlson, S. J., Tuckerman, J., Kaufman, J., Moore, H. C., Seale, H., . . . Danchin, M. (2021). The Collaboration for Increasing Influenza Vaccination in Children (CIIVIC): a meeting report. Australian and New Zealand Journal of Public Health, 45(3), 193-196. DOI
2021	Oliver, J., Thielemans, E., McMinn, A., Baker, C., Britton, P. N., Clark, J. E., . . . Crawford, N. W. (2021). Correction to: Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study (BMC Public Health, (2019), 19, 1, (1750), 10.1186/s12889-019-8085-2). BMC Public Health, 21(1), 855. DOI
2021	Madhi, S. A., Polack, F. P., Piedra, P. A., Munoz, F. M., Trenholme, A. A., Simões, E. A. F., . . . Fries, L. F. (2021). Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. Obstetrical and Gynecological Survey, 76(1), 10-13. DOI Scopus1
2021	Davies, C., Stoney, T., Hutton, H., Parrella, A., Kang, M., Macartney, K., . . . Skinner, S. R. (2021). School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination. Vaccine, 39(40), 4190-4198. DOI Scopus2 WoS2 Europe PMC2
2021	Morello, B. R., Milazzo, A., Marshall, H. S., & Giles, L. C. (2021). Lessons for and from the COVID-19 pandemic response — An appraisal of guidance for the public health management of Invasive Meningococcal Disease. Journal of Infection and Public Health, 14(8), 1069-1074. DOI
2021	Clarke, M., Goodchild, L. M., Evans, S., Giles, L., Sullivan, S., Barr, I. G., . . . Marshall, H. (2021). Body mass index and vaccine responses following influenza vaccination during pregnancy.. Vaccine, 39(34), 4864-4870. DOI Scopus1
2021	Mohammed, H., McMillan, M., & Marshall, H. S. (2021). Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia. Human Vaccines & Immunotherapeutics, 18(1), 1-9. DOI
2021	McHugh, L., O'Grady, K. A. F., Nolan, T., Richmond, P. C., Wood, N., Marshall, H. S., . . . Andrews, R. M. (2021). National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012–2015. Australian and New Zealand Journal of Public Health, 45(5), 455-461. DOI Scopus1 WoS1
2021	Carlson, S. J., Quinn, H. E., Blyth, C. C., Cheng, A., Clark, J., Francis, J. R., . . . Leask, J. (2021). Barriers to influenza vaccination of children hospitalised for acute respiratory illness: a cross-sectional survey. Journal of Paediatrics and Child Health, 57(3), 409-418. DOI Scopus4 WoS5 Europe PMC2
2021	Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Verburg, P., Dekker, G., & Marshall, H. S. (2021). Safety of maternal pertussis vaccination on pregnancy and birth outcomes: a prospective cohort study. Vaccine, 39(2), 324-331. DOI Scopus2 WoS2 Europe PMC1
2021	Marshall, H. S., Andraweera, P. H., Wang, B., McMillan, M., Koehler, A. P., Lally, N., . . . Flood, L. (2021). Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol. Human Vaccines and Immunotherapeutics, 17(5), 1450-1454. DOI Scopus2 WoS2 Europe PMC2
2021	Strachan, R., Homaira, N., Beggs, S., Bhuiyan, M. U., Gilbert, G. L., Lambert, S. B., . . . Jaffé, A. (2021). Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax, 76(5), 487-493. DOI Scopus6 WoS5 Europe PMC3
2021	McMillan, M., Wang, B., Koehler, A. P., Sullivan, T. R., & Marshall, H. S. (2021). Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents.. Clin Infect Dis, 73(1), e233-e237. DOI Scopus6 WoS3 Europe PMC1
2021	Rahaman, M. R., Marshall, H., Milazzo, A., Crabb, D., & Bi, P. (2021). Q fever prevention and vaccination: Australian livestock farmers' knowledge and attitudes to inform a One Health approach. One Health, 12, 100232-1-100232-9. DOI Scopus2 WoS2
2021	McMillan, M., Walters, L., Sullivan, T., Leong, L. E. X., Turra, M., Lawrence, A., . . . Marshall, H. S. (2021). Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(1), e99-e106. DOI Scopus10 WoS9 Europe PMC3
2020	Parikh, S. R., Campbell, H., Bettinger, J. A., Harrison, L. H., Marshall, H. S., Martinon-Torres, F., . . . Ladhani, S. N. (2020). The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. Journal of Infection, 81(4), 483-498. DOI Scopus53 WoS48 Europe PMC17
2020	McRae, J. E., Quinn, H. E., Saravanos, G. L., Carlson, S. J., Britton, P. N., Crawford, N. W., . . . Macartney, K. K. (2020). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence (2018), 44. DOI Scopus1 Europe PMC1
2020	Top, K., Macartney, K., Bettinger, J., Tan, B., Blyth, C., Marshall, H., . . . McIntyre, P. (2020). Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia. Eurosurveillance, 25(25), 1-12. DOI Scopus4 WoS5 Europe PMC4
2020	Rahaman, M. R., Milazzo, A., Marshall, H., & Bi, P. (2020). Spatial, temporal, and occupational risks of Q fever infection in South Australia, 2007-2017.. Journal of infection and public health, 13(4), 544-551. DOI Scopus5 WoS5
2020	Marshall, H. S., Lally, N., Flood, L., & Phillips, P. (2020). First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia. Medical Journal of Australia, 212(2), 89-93. DOI Scopus9 WoS9 Europe PMC2
2020	Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., MacLennan, J. M., . . . Richmond, P. (2020). Meningococcal B vaccine and meningococcal carriage in adolescents in Australia. The New England Journal of Medicine, 382(4), 318-327. DOI Scopus81 WoS79 Europe PMC36
2020	Tuckerman, J., Marshall, H., Snape, M., Collins, J., Straube, S., & Chambers, A. G. (2020). Interventions for increasing the uptake of immunisation in healthcare workers. Cochrane Database of Systematic Reviews, 2020(1). DOI
2020	Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L., Leemaqz, S., Dalton, J., . . . Marshall, H. S. (2020). Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.. Vaccine, 38(17), 3358-3368. DOI Scopus11 WoS10 Europe PMC6
2020	Thielemans, E., Oliver, J., McMinn, A., Baker, C., Britton, P. N., Clark, J., . . . Steer, A. C. (2020). Clinical description and outcomes of Australian children with invasive group A streptococcal disease. Pediatric Infectious Disease Journal, 39(5), 379-384. DOI Scopus5 WoS5 Europe PMC4
2020	Blyth, C. C., Cheng, A. C., Crawford, N. W., Clark, J. E., Buttery, J. P., Marshall, H. S., . . . Macartney, K. K. (2020). The impact of new universal child influenza programs in Australia: vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018. Vaccine, 38(13), 2779-2787. DOI Scopus9 WoS8 Europe PMC2
2020	Menzies, R., Heron, L., Lampard, J., McMillan, M., Joseph, T., Chan, J., . . . Marshall, H. (2020). A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants. Vaccine, 38(15), 3137-3142. DOI Scopus5 WoS5 Europe PMC4
2020	Pearce, J., Peters, M., May, N., Marshall, H., Hein, C., & Grantham, H. (2020). Care of the patient with invasive meningococcal disease by prehospital emergency medical service clinicians: a scoping review. BMJ Open, 10(2), e033447-1-e033447-11. DOI Scopus3 WoS3 Europe PMC2
2020	Wnukowski-Mtonga, P., Jayasinghe, S., Chiu, C., Macartney, K., Brotherton, J., Donovan, B., . . . Marshall, H. (2020). Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Communicable diseases intelligence (2018), 44, 12 pages. DOI Scopus1 Europe PMC1
2020	Tuckerman, J., Crawford, N. W., & Marshall, H. S. (2020). Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination. PLoS One, 15(4), e0230425. DOI Scopus4 WoS4 Europe PMC3
2020	Kaufman, J., Attwell, K., Tuckerman, J., O'Sullivan, J., Omer, S. B., Leask, J., . . . Danchin, M. (2020). Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study. Vaccine, 38(24), 4024-4031. DOI Scopus6 WoS6 Europe PMC2
2020	Tuckerman, J., Crawford, N. W., & Marshall, H. S. (2020). Seasonal influenza vaccination for children with special risk medical conditions: Does policy meet practice?. J Paediatr Child Health, 56(9), 1388-1395. DOI Scopus4 WoS4 Europe PMC2
2020	Britton, P. N., Dale, R. C., Blyth, C. C., Clark, J. E., Crawford, N., Marshall, H., . . . Jones, C. A. (2020). Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study. Clinical Infectious Diseases, 70(12), 2517-2526. DOI Scopus14 WoS14 Europe PMC4
2020	Tuckerman, J. L., Kaufman, J., Danchin, M., & Marshall, H. S. (2020). Influenza vaccination: a qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions. Vaccine, 38(49), 7806-7814. DOI
2020	McMillan, M., Chandrakumar, A., Wang, H. L. R., Clarke, M., Sullivan, T. R., Andrews, R. M., . . . Marshall, H. S. (2020). Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(3), E609-E619. DOI Scopus4 WoS5 Europe PMC1
2020	Clarke, M., Liew, Y., Mathew, S., & Marshall, H. (2020). Clinical Severity of Gastroenteritis in Children Hospitalized With Rotavirus Infection Before and Post Introduction of a National Rotavirus Vaccination Program in Australia. The Pediatric infectious disease journal, 39(9), e289-e290. DOI
2020	Marshall, H. S., Koehler, A. P., Wang, B., A'Houre, M., Gold, M., Quinn, H., . . . Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922. DOI Scopus5 WoS4 Europe PMC1
2020	Aye, A. M. M., Bai, X., Borrow, R., Bory, S., Carlos, J., Caugant, D. A., . . . Zhu, B. (2020). Meningococcal disease surveillance in the Asia-Pacific region (2020): the Global Meningococcal Initiative.. J Infect, 81(5), 698-711. DOI Scopus17 WoS17 Europe PMC11
2020	Madhi, S., Polack, F., Piedra, P., Munoz, F., Trenholme, A., Simões, E., . . . Fries, L. (2020). Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. The New England journal of medicine, 383(5), 426-439. DOI Scopus104 WoS96 Europe PMC69
2020	Marshall, H., & Wood, N. (2020). The potential for improved protection against pertussis. The Lancet Infectious Diseases, 20(11), 1220-1222. DOI Scopus1 Europe PMC1
2020	Marshall, H. S., & Maiden, M. C. J. (2020). The impact of a meningococcal protein-based serogroup B vaccine on serogroup W invasive disease in children.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(7), e1669-e1672. DOI Scopus1
2020	Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Dekker, G. A., & Marshall, H. S. (2020). Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study. EClinicalMedicine, 26, 1-9. DOI Scopus5 WoS4 Europe PMC3
2019	Pearce, J., Peters, M. D. J., May, N., Marshall, H., Hein, C., & Grantham, H. (2019). Care of the patient with invasive meningococcal disease by emergency medical service clinicians: A scoping review protocol. Australasian Journal of Paramedicine, 16, 1-7. DOI Scopus1
2019	Marshall, H. S., Baber, J., Richmond, P., Nissen, M., Shakib, S., Kreiswirth, B. N., . . . Anderson, A. S. (2019). S. aureus Colonization in Healthy Australian Adults Receiving an Investigational S. aureus 3-antigen Vaccine.. The Journal of infection, 79(6), 582-592. DOI Scopus1 WoS1
2019	Wang, B., Hajiali Afzali, H., Giles, L., & Marshall, H. (2019). Lifetime costs of invasive meningococcal disease: a Markov model approach. Vaccine, 37(46), 6885-6893. DOI Scopus4 WoS2 Europe PMC4
2019	Wooldridge, A. L., McMillan, M., Kaur, M., Giles, L. C., Marshall, H. S., & Gatford, K. L. (2019). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review. Journal of Allergy and Clinical Immunology, 144(6), 1703-1713. DOI Scopus6 WoS4 Europe PMC2
2019	MacIntyre, C., Shaw, P., Mackie, F., Boros, C., Marshall, H., Seale, H., . . . Stormon, M. (2019). Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine, 37(37), 5630-5636. DOI Scopus6 WoS7 Europe PMC4
2019	Tuckerman, J., Misan, S., Crawford, N. W., & Marshall, H. S. (2019). Influenza in Children With Special Risk Medical Conditions: A Systematic Review and Meta-analysis. The Pediatric infectious disease journal, 38(9), 912-919. DOI Scopus7
2019	Carlson, S., Scanlan, C., Marshall, H., Blyth, C., Macartney, K., & Leask, J. (2019). Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. Vaccine, 37(40), 5994-6001. DOI Scopus8 WoS9 Europe PMC2
2019	McMillan, M., Walters, L., Mark, T., Lawrence, A., Leong, L., Sullivan, T., . . . Marshall, H. (2019). B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia. Human Vaccines and Immunotherapeutics, 15(4), 987-994. DOI Scopus17 WoS15 Europe PMC9
2019	Quinn, H., Gidding, H., Marshall, H., Booy, R., Elliott, E., Richmond, P., . . . Macartney, K. (2019). Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. Journal of Infection, 78(3), 220-225. DOI Scopus10 WoS10 Europe PMC7
2019	Tuckerman, J., Crawford, N. W., Lynch, J., & Marshall, H. S. (2019). Are children with special risk medical conditions receiving influenza vaccination? Validity of parental and provider report, and to a National Immunisation Register. Human Vaccines and Immunotherapeutics, 15(4), 951-958. DOI Scopus3 WoS5 Europe PMC2
2019	Nolan, T., Santolaya, M., de Looze, F., Marshall, H., Richmond, P., Henein, S., . . . O'Ryan, M. (2019). Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine. Vaccine, 37(9), 1209-1218. DOI Scopus19 WoS17 Europe PMC8
2019	McRae, J. E., Quinn, H. E., Saravanos, G. L., McMinn, A., Britton, P. N., Wood, N., . . . Macartney, K. (2019). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence (2018), 43. DOI Scopus4 Europe PMC4
2019	Rahaman, M. R., Milazzo, A., Marshall, H., & Bi, P. (2019). Is a One Health Approach Utilized for Q Fever Control? A Comprehensive Literature Review.. International journal of environmental research and public health, 16(5), 22 pages. DOI Scopus14 WoS16 Europe PMC9
2019	Goh, A. E. N., Choi, E. H., Chokephaibulkit, K., Choudhury, J., Kuter, B., Lee, P. I., . . . Wolfson, L. J. (2019). Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Review of Vaccines, 18(5), 475-493. DOI Scopus11 WoS11 Europe PMC8
2019	Mohammed, H., McMillan, M., Roberts, C. T., & Marshall, H. S. (2019). A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.. PloS one, 14(3), 0214538. DOI Scopus17 WoS15 Europe PMC5
2019	Wang, B., Santoreneos, R., Giles, L., Haji Ali Afzali, H., & Marshall, H. (2019). Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine, 37(21), 2768-2782. DOI Scopus61 WoS60 Europe PMC30
2019	Marshall, H., McMillan, M., Koehler, A., Lawrence, A., MacLennan, J., Maiden, M., . . . Vadivelu, K. (2019). B part of it school leaver protocol: An observational repeat cross-sectional study to assess the impact of a meningococcal serogroup b (4cmenb) vaccine programme on carriage of neisseria meningitidis. BMJ Open, 9(5), 1-7. DOI Scopus6 WoS6 Europe PMC2
2019	Nolan, T., Booy, R., Marshall, H., Richmond, P., Nissen, M., Ziegler, J., . . . Van der Wielen, M. (2019). Immunogenicity and safety of a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine 6 years after MenC priming as toddlers. The Pediatric Infectious Disease Journal, 38(6), 643-650. DOI Scopus3 WoS2 Europe PMC1
2019	Marshall, H. S., & Amirthalingam, G. (2019). Protecting pregnant women and their newborn from life-threatening infections. Medical Journal of Australia, 210(10), 445-446. DOI
2019	Marshall, H., McMillan, M., Wang, B., Booy, R., Afzali, H., Buttery, J., . . . Barton, B. (2019). AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.. BMJ Open, 9(12), e032583. DOI Scopus2 WoS2 Europe PMC1
2019	Oliver, J., Thielemans, E., McMinn, A., Baker, C., Britton, P. N., Clark, J. E., . . . Crawford, N. W. (2019). Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study. BMC Public Health, 19(1), 1750-1-1750-10. DOI Scopus9 WoS10 Europe PMC4
2019	Marshall, H., Clarke, M., Heath, C., Quinn, H., Richmond, P., Crawford, N., . . . Macartney, K. (2019). Severe and complicated varicella and associated genotypes 10 years after introduction of a one-dose varicella vaccine program. Journal of Infectious Diseases, 219(3), 391-399. DOI Scopus4 WoS3 Europe PMC2
2019	McHugh, L., Marshall, H. S., Perrett, K. P., Nolan, T., Wood, N., Lambert, S. B., . . . Andrews, R. M. (2019). The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum study. Clinical Infectious Diseases, 68(3), 402-408. DOI Scopus16 WoS14 Europe PMC10
2019	Butler, J., Gunnarsson, R., Traves, A., & Marshall, H. (2019). Severe respiratory syncytial virus infection in hospitalized children less than 3 years of age in a temperate and tropical climate. Pediatric Infectious Disease Journal, 38(1), 6-11. DOI Scopus2
2019	Blyth, C. C., Macartney, K. K., McRae, J., Clark, J. E., Marshall, H. S., Buttery, J., . . . Influenza Complications Alert Network (FluCAN) Collaboration. (2019). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948. DOI Scopus34 WoS35 Europe PMC13
2018	Patel, C., Brotherton, J., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., & Marshall, H. (2018). The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?. Eurosurveillance, 23(41), 30-40. DOI Scopus105 WoS83 Europe PMC34
2018	Wood, N., Nolan, T., & Marshall, H. (2018). Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial. Clinical Infectious Diseases, 172(11), 1045-1052. DOI Scopus24 WoS22 Europe PMC10
2018	Cyra, P., Brotherton, J., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., & Marshall, H. (2018). The impact of ten years of HPV vaccination in Australia: what additional disease burden could a 9-valent vaccine prevent?. Eurosurveillance, 23(41), 30-40. DOI
2018	Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., . . . Lynn, D. (2018). Early-life antibiotic-driven dysbiosis in mice leads to impaired antibody responses and enhanced T cell cytokine recall responses to vaccination. Cell Host and Microbe.
2018	Marshall, H., & Plotkin, S. (2018). The changing epidemiology of mumps in a high vaccination era. The Lancet Infectious Diseases, 19(2), 118-119. DOI Scopus12 Europe PMC6
2018	Blyth, C., Macartney, K., McRae, J., Clark, J., Marshall, H., Buttery, J., . . . Paediatric Active Enhanced Disease Surveillance (PAEDS). (2018). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017. Clinical Infectious Diseases, 1-9.
2018	Bedford, H., Attwell, K., Danchin, M., Marshall, H., Corben, P., & Leask, J. (2018). Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology. Vaccine, 36(44), 6556-6558. DOI Scopus101 WoS90 Europe PMC43
2018	Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., . . . Lynn, D. (2018). Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice. Cell Host and Microbe, 23(5), 653-660. DOI Scopus74 WoS70 Europe PMC52
2018	Mohammed, H., Clarke, M., Koehler, A., Watson, M., & Marshall, H. (2018). Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS ONE, 13(6), e0197867-1-e0197867-14. DOI Scopus45 WoS41 Europe PMC23
2018	Wang, B., Santoreneos, R., Afzali, H., Giles, L., & Marshall, H. (2018). Costs of invasive meningococcal disease: a global systematic review. PharmacoEconomics, 36(10), 1201-1222. DOI Scopus16 WoS13 Europe PMC10
2018	Marshall, H. S., McMillan, M., Koehler, A., Lawrence, A., Maclennan, J. M., Maiden, M. C. J., . . . Vadivelu, K. (2018). B Part of It protocol: A cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open, 8(7), 9 pages. DOI Scopus21 WoS18 Europe PMC15
2018	Quinn, H., Marshall, H., & Macartney, K. (2018). Varicella vaccine effectiveness after a 10 year immunization program in Australia. Journal of Infection.
2018	Cutland, C., Nolan, T., Halperin, S., Kurugol, Z., Ahmed, K., Perrett, K., . . . Van Der Wielen, M. (2018). Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. Vaccine, 36(14), 1908-1916. DOI Scopus14 WoS13 Europe PMC7
2018	Tuckerman, J., Misan, S., Salih, S., Joseph Xavier, B., Crawford, N., Lynch, J., & Marshall, H. (2018). Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions. Vaccine, 36(52), 8138-8147. DOI Scopus12 WoS13 Europe PMC5
2018	Marshall, H. S., Vesikari, T., Richmond, P. C., Szenborn, L., Beeslaar, J., Maguire, J. D., . . . Investigators, B. 1. 9. 7. 1. 0. 3. 5. S. (2018). A Phase 2 Study of the Immunogenicity, Safety, and Tolerability of MenB-FHbp, a Bivalent Meningococcal B Vaccine, in Healthy Toddlers.
2017	Fell, D., Azziz-Baumgartner, E., Baker, M., Batra, M., Beauté, J., Beutels, P., . . . Ortiz, J. (2017). Influenza epidemiology and immunization during pregnancy: final report of a World Health Organization working group. Vaccine, 35(43), 5738-5750. DOI Scopus62 WoS62 Europe PMC43
2017	DeSilva, M., Munoz, F. M., Sell, E., Marshall, H., Tse Kawai, A., Kachikis, A., . . . Bardají, A. (2017). Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Vaccine, 35(48), 6472-6482. DOI Scopus24 WoS28 Europe PMC16
2017	Sweet, L., Keech, C., Klein, N., Marshall, H., Tagbo, B., Quine, D., . . . Muñoz, F. (2017). Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine, 35(48), 6506-6517. DOI Scopus12 WoS13 Europe PMC8
2017	Marshall, H., Richmond, P., Beeslaar, J., Jiang, Q., Jansen, K., Garcés-Sánchez, M., . . . Perez, J. (2017). Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 17(1), 58-67. DOI Scopus30 WoS27 Europe PMC14
2017	McMillan, M., Clarke, M., Parrella, A., Fell, D., Amirthalingam, G., & Marshall, H. (2017). Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review. Obstetrics and Gynecology, 129(3), 560-573. DOI Scopus64 WoS53 Europe PMC25
2017	McHugh, L., Andrews, R. M., Lambert, S. B., Viney, K. A., Wood, N., Perrett, K. P., . . . O'Grady, K. A. F. (2017). Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: the FluMum study. Vaccine, 35(10), 1403-1409. DOI Scopus22 WoS21 Europe PMC14
2017	Forster, A., Mahendran, K., Davies, C., Stoney, T., Marshall, H., McGeechan, K., . . . Skinner, S. (2017). Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety. Public Health, 147, 77-83. DOI Scopus14 WoS14 Europe PMC6
2017	Davies, C., Skinner, S., Stoney, T., Marshall, H., Collins, J., Jones, J., . . . Zimet, G. (2017). 'Is it like one of those infectious kind of things?' The importance of educating young people about HPV and HPV vaccination at school. Sex Education, 17(3), 256-275. DOI Scopus21 WoS17
2017	Britton, P., Blyth, C., Macartney, K., Dale, R., Li-Kim-Moy, J., Khandaker, G., . . . Jones, C. (2017). The spectrum and burden of influenza-associated neurological disease in children: combined encephalitis and influenza sentinel site surveillance from Australia 2013-2015. Clinical Infectious Diseases, 65(4), 653-660. DOI Scopus45 WoS46
2017	Katz, M., Gessner, B., Johnson, J., Skidmore, B., Knight, M., Bhat, N., . . . Fell, D. (2017). Incidence of influenza virus infection among pregnant women: A systematic review. BMC Pregnancy and Childbirth, 17(1), 12 pages. DOI Scopus27 WoS27 Europe PMC18
2017	Costa-Pinto, J., Willaby, H., Leask, J., Wood, N., Marshall, H., & Danchin, M. (2017). Vaccine discussions with parents: The experience of Australian paediatricians. Journal of Paediatrics and Child Health, 53(9), 855-861. DOI Scopus7 WoS7 Europe PMC5
2017	Katz, M. A., Gessner, B. D., Johnson, J., Skidmore, B., Knight, M., Bhat, N., . . . Fell, D. B. (2017). Erratum: Incidence of influenza virus infection among pregnant women: A systematic review [BMC Pregnancy and Childbirth., 17, 1, (2017) (155)] DOI:10.1186/s12884-017-1333-5. BMC Pregnancy and Childbirth, 17(1), 1 page. DOI Scopus2 WoS2 Europe PMC2
2017	Britton, P., Dale, R., Blyth, C., Macartney, K., Crawford, N., Marshall, H., . . . Jones, C. (2017). Influenza-associated encephalitis/encephalopathy identified by the Australian Childhood Encephalitis study 2013-2015. Pediatric Infectious Disease Journal, 36(11), 1021-1026. DOI Scopus34 WoS37 Europe PMC15
2017	Wang, B., Chen, G., Ratcliffe, J., Afzali, H., Giles, L., & Marshall, H. (2017). Adolescent values for immunisation programs in Australia: a discrete choice experiment. PLoS ONE, 12(7), e0181073-1-e0181073-14. DOI Scopus12 WoS11 Europe PMC9
2017	Danchin, M., Costa-Pinto, J., Atwell, K., Willaby, H., Wiley, K., Hoq, M., . . . Marshall, H. (2017). Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. Vaccine, 36(44), 6473-6479. DOI Scopus70 WoS63 Europe PMC30
2017	Britton, P. N., Blyth, C. C., Macartney, K., Dale, R. C., Li-Kim-Moy, J., Khandaker, G., . . . Australian Childhood Encephalitis (ACE) Study Investigators, Influenza Complications Alert Network (FluCAN) Investigators, and Paediatric Active Enhanced Disease Surveillance (PAEDS) Network. (2017). The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(4), 653-660. DOI Europe PMC25
2017	Tooher, R., collins, J., Braunack-Mayer, A., burgess, T., Skinner, S., O'keefe, M., . . . Marshall, H. (2017). Intersectoral collaboration to implement school-based health programmes: Australian perspectives. Health Promotion International, 32(2), 312-321. DOI Scopus25 WoS22 Europe PMC9
2017	Fell, D., Savitz, D., Kramer, M., Gessner, B., Katz, M., Knight, M., . . . Ortiz, J. (2017). Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG: An International Journal of Obstetrics and Gynaecology, 124(1), 48-59. DOI Scopus84 WoS78 Europe PMC47
2016	Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., . . . Lan, R. (2016). Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine, 34(34), 3967-3971. DOI Scopus18 WoS18 Europe PMC13
2016	Lakhan, N., Clarke, M., Mathew, S., & Marshall, H. (2016). Retrospective review of factors associated with severe hospitalised community-acquired influenza in a tertiary paediatric hospital in South Australia. Influenza and other Respiratory Viruses, 10(6), 479-485. DOI Scopus5 WoS5 Europe PMC3
2016	MacIntyre, C., Shaw, P., Mackie, F., Boros, C., Marshall, H., Barnes, M., . . . Stormon, M. (2016). Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine, 34(36), 4343-4350. DOI Scopus19 WoS18 Europe PMC9
2016	DeSilva, M., Munoz, F. M., Mcmillan, M., Kawai, A. T., Marshall, H., Macartney, K. K., . . . Kharbanda, E. O. (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015-6026. DOI Scopus39 WoS34 Europe PMC14
2016	Marshall, H., Nissen, M., Richmond, P., Shakib, S., Jiang, Q., Cooper, D., . . . Girgenti, D. (2016). Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study. Journal of Infection, 73(5), 437-454. DOI Scopus10 WoS9 Europe PMC6
2016	Mcbride, W., Abhayaratna, W., Barr, I., Booy, R., Carapetis, J., Carson, S., . . . Greenberg, M. (2016). Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial. Vaccine, 34(41), 4991-4997. DOI Scopus7 WoS6 Europe PMC5
2016	Cooper, S., Davies, C., McBride, K., Blades, J., Stoney, T., Marshall, H., & Skinner, S. (2016). Development of a human papillomavirus vaccination intervention for Australian adolescents. Health Education Journal, 75(5), 610-620. DOI Scopus9 WoS8
2016	Wang, B., Giles, L., Afzali, H., Clarke, M., Ratcliffe, J., Chen, G., & Marshall, H. (2016). Adolescent confidence in immunisation: assessing and comparing attitudes of adolescents and adults. Vaccine, 34(46), 5595-5603. DOI Scopus10 WoS8 Europe PMC5
2016	Safarchi, A., Octavia, S., Wu, S., Kaur, S., Sintchenko, V., Gilbert, G., . . . Lan, R. (2016). Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. Journal of Infection, 72(4), 468-477. DOI Scopus25 WoS24 Europe PMC18
2016	Tuckerman, J., Thomas, N., & Marshall, H. (2016). Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation. Vaccine, 34(14), 1726-1732. DOI Scopus6 WoS4 Europe PMC4
2016	Marshall, H., McMillan, M., Andrews, R., Macartney, K., & Edwards, K. (2016). Vaccines in pregnancy: the dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics, 12(4), 848-856. DOI Scopus41 WoS41 Europe PMC23
2016	Parrella, A., Braunack-Mayer, A., Collins, J., Clarke, M., Tooher, R., Ratcliffe, J., & Marshall, H. (2016). Prioritizing government funding of adolescent vaccinations: recommendations from young people on a citizens' jury. Vaccine, 34(31), 3592-3597. DOI Scopus6 WoS4 Europe PMC2
2016	Clarke, M., McIntyre, P., Blyth, C., Wood, N., Octavia, S., Sintchenko, V., . . . Marshall, H. (2016). The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Journal of Infection, 72(2), 171-178. DOI Scopus24 WoS25 Europe PMC20
2016	Burgess, T., Braunack-Mayer, A., Tooher, R., Collins, J., O'Keefe, M., Skinner, R., . . . Marshall, H. (2016). Optimizing intersectoral collaboration between health and education: the Health Bridges study. Journal of Public Health, 38(4), e430-e437. DOI Scopus11 WoS5 Europe PMC4
2016	Marshall, H., Chen, G., Clarke, M., & Ratcliffe, J. (2016). Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a Discrete Choice Experiment. Vaccine, 34(5), 671-677. DOI Scopus34 WoS31 Europe PMC27
2016	Wooldridge, A., McMillan, M., Marshall, H., & Gatford, K. (2016). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 14(11), 11-20. DOI Scopus4
2016	Marshall, H., Wang, B., Wesselingh, S., Snape, M., & Pollard, A. J. (2016). Control of invasive meningococcal disease: Is it achievable?. International Journal of Evidence-Based Healthcare, 14(1), 3-12. DOI Scopus8 WoS9 Europe PMC3
2016	Tuckerman, J., Shrestha, L., Collins, J., & Marshall, H. (2016). Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia. Human Vaccines and Immunotherapeutics, 12(7), 1749-1756. DOI Scopus7 WoS5 Europe PMC2
2015	La Vincente, S., Mielnik, D., Jenkins, K., Bingwor, F., Volavola, L., Marshall, H., . . . Mulholland, E. (2015). Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents. BMC Public Health, 15(1), 1257-1-1257-11. DOI Scopus11 WoS9 Europe PMC9
2015	Pearce, A., Marshall, H., Bedford, H., & Lynch, J. (2015). Barriers to childhood immunisation: findings from the Longitudinal Study of Australian Children. Vaccine, 33(29), 3377-3383. DOI Scopus53 WoS47 Europe PMC25
2015	Braunack-Mayer, A., Skinner, S., Collins, J., Tooher, R., Proeve, C., O'Keefe, M., . . . Marshall, H. (2015). Ethical challenges in school-based immunization programs for adolescents: a qualitative study. American Journal of Public Health, 105(7), 1399-1403. DOI Scopus14 WoS13 Europe PMC11
2015	Tuckerman, J., Collins, J., & Marshall, H. (2015). Factors affecting uptake of recommended immunizations among health care workers in South Australia. Human Vaccines and Immunotherapeutics, 11(3), 704-712. DOI Scopus25 WoS24 Europe PMC13
2015	Nissen, M., Marshall, H., Richmond, P., Shakib, S., Jiang, Q., Cooper, D., . . . Girgenti, D. (2015). A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. Vaccine, 33(15), 1846-1854. DOI Scopus48 WoS49 Europe PMC32
2015	McMillan, M., Porritt, K., Kralik, D., Costi, L., & Marshall, H. (2015). Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine, 33(18), 2108-2117. DOI Scopus102 WoS98 Europe PMC70
2015	Wong, C., Thomas, N., Clarke, M., Boros, C., Tuckerman, J., & Marshall, H. (2015). Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunzations. Human Vaccines and Immunotherapeutics, 11(5), 1165-1172. DOI Scopus29 WoS28 Europe PMC12
2015	Marshall, H., Richmond, P., Nissen, M., Lambert, S., Booy, R., Reynolds, G., . . . Scully, I. (2015). Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in Australia. Pediatric Infectious Disease Journal, 34(8), 831-838. DOI Scopus8 WoS8 Europe PMC5
2015	Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., . . . Lan, R. (2015). Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine, 33(46), 6277-6281. DOI Scopus58 WoS59 Europe PMC41
2015	Clarke, M., Thomas, N., Giles, L., & Marshall, H. (2015). Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults. Vaccine, 33(51), 7337-7343. DOI Scopus6 WoS5 Europe PMC3
2015	Perrett, K., McVernon, J., Richmond, P., Marshall, H., Nissen, M., August, A., . . . Nolan, T. (2015). Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study. Vaccine, 33(39), 5217-5224. DOI Scopus29 WoS28 Europe PMC19
2015	Skinner, S., Davies, C., Cooper, S., Stoney, T., Marshall, H., Jones, J., . . . McGeechan, K. (2015). HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents. BMC Public Health, 15(1), 896-1-896-9. DOI Scopus17 WoS12 Europe PMC6
2015	Booy, R., Nolan, T., Reynolds, G., Richmond, P., Nissen, M., Marshall, H., . . . Miller, J. (2015). Five-year antibody persistence and safety after a single dose of combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in Haemophilus influenzae Type B-primed toddlers. Pediatric Infectious Disease Journal, 34(12), 1379-1384. DOI Scopus4 WoS4 Europe PMC2
2015	Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., . . . Wood, N. (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. DOI Scopus24 WoS21 Europe PMC10
2015	Marshall, H., Clarke, M., Rasiah, K., Richmond, P., Buttery, J., Reynolds, G., . . . Mcintyre, P. (2015). Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatric Infectious Disease Journal, 34(4), 339-345. DOI Scopus39 WoS42 Europe PMC23
2014	Nolan, T., Izurieta, P., Lee, B., Chan, P., Marshall, H., Booy, R., . . . Vaughn, D. (2014). Heterologous prime-boost vaccination using an ASO3B-adjuvanted influenza A(H5N1) vaccine in infants and children <3 years of age. Journal of Infectious Diseases, 210(11), 1800-1810. DOI Scopus14 WoS13 Europe PMC9
2014	McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2014). Influenza vaccination during pregnancy: A systematic review of effectiveness and safety. JBI Database of Systematic Reviews and Implementation Reports, 12(6), 281-381. DOI Scopus4
2014	Wang, B., Clarke, M., Thomas, N., Howell, S., Afzali, H., & Marshall, H. (2014). The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children. Pediatric Infectious Disease Journal, 33(3), 316-318. DOI Scopus19 WoS19 Europe PMC10
2014	O'Grady, K., McHugh, L., Nolan, T., Richmond, P., Wood, N., Marshall, H., . . . Andrews, R. (2014). FluMum: a prospective cohort study of mother-infant pairs assessing the effectiveness of maternal influenza vaccination in revention of influenza in early infancy. BMJ Open, 4(6), e005676-1-e005676-6. DOI Scopus11 WoS13 Europe PMC9
2014	Taylor, K., Stocks, N., & Marshall, H. (2014). The missing link: family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines. Vaccine, 32(33), 4214-4219. DOI Scopus8 WoS8 Europe PMC6
2014	Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., . . . Elliott, E. (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645. DOI Scopus21 WoS13 Europe PMC14
2014	Collins, J., Alona, I., Tooher, R., & Marshall, H. (2014). Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated. Human Vaccines and Immunotherapeutics, 10(10), 2922-2929. DOI Scopus32 WoS27 Europe PMC22
2014	Wood, N., Marshall, H., White, O., Holt, P., & McIntyre, P. (2014). Antibody and cell-mediated immunity to pertussis 4 years after monovalent acellular pertussis vaccine at birth. Pediatric Infectious Disease Journal, 33(5), 511-517. DOI Scopus10 WoS10 Europe PMC6
2014	Wang, B., Haji Ali Afzali, H., & Marshall, H. (2014). The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine, 32(37), 4791-4798. DOI Scopus28 WoS21 Europe PMC15
2014	Webb, H., Street, J., & Marshall, H. (2014). Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations. Human Vaccines & Immunotherapeutics, 10(4), 1114-1121. DOI Scopus31 WoS26 Europe PMC23
2014	Lam, C., & Marshall, H. (2014). Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging Infectious Diseases, 20(4), 626-633. DOI Scopus129 WoS132 Europe PMC92
2014	Marshall, H., Proeve, C., Collins, J., Tooher, R., O'Keefe, M., Burgess, T., . . . Braunack-Mayer, A. (2014). Eliciting youth and adult recommendations through citizens' juries to improve school based adolescent immunisation programs. Vaccine, 32(21), 2434-2440. DOI Scopus18 WoS17 Europe PMC11
2014	Parrella, A., Gold, M., Braunack-Mayer, A., Baghurst, P., & Marshall, H. (2014). Consumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFI. Human Vaccines & Immunotherapeutics, 10(3), 747-754. DOI Scopus9 WoS9 Europe PMC9
2014	Wang, B., Clarke, M., Hajiali Afzali, H., & Marshall, H. (2014). Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine, 32(18), 2042-2049. DOI Scopus16 WoS14 Europe PMC12
2014	Marshall, H., Clarke, M., & Sullivan, T. (2014). Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine, 32(3), 338-344. DOI Scopus28 WoS26 Europe PMC19
2014	Tuckerman, J., Marshall, H., Snape, M., Collins, J., Straube, S., & Chambers, A. G. (2014). Interventions for increasing the uptake of immunisation in healthcare workers. Cochrane Database of Systematic Reviews, 2014(11). DOI
2013	Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., . . . Liu, S. (2013). International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. DOI Scopus79 WoS73 Europe PMC49
2013	Tooher, R., Collins, J., Street, J., Braunack-Mayer, A., & Marshall, H. (2013). Community knowledge, behaviours and attitudes about the 2009 H1N1 influenza pandemic: a systematic review. Influenza and Other Respiratory Viruses, 7(6), 1316-1327. DOI Scopus44 WoS43 Europe PMC25
2013	Parrella, A., Braunack-Mayer, A., Gold, M., Marshall, H., & Baghurst, P. (2013). Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Services Research, 13(313), 1-12. DOI Scopus22 WoS22 Europe PMC12
2013	Lambert, S., Chuk, L., Nissen, M., Nolan, T., McVernon, J., Booy, R., . . . Lai, M. (2013). Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents. Influenza and Other Respiratory Viruses, 7(5), 676-685. DOI Scopus16 WoS16 Europe PMC6
2013	Marshall, H., Clarke, M., Evans, S., Piotto, L., & Gent, R. (2013). Randomized trial using ultrasound to assess intramuscular vaccination at a 60 degrees or 90 degrees needle angle. Vaccine, 31(23), 2647-2652. DOI Scopus6 WoS5 Europe PMC5
2013	Marshall, H., Collins, J., Sullivan, T., Tooher, R., O'Keefe, M., Skinner, S., . . . Braunack-Mayer, A. (2013). Parental and societal support for adolescent immunization through school based immunization programs. Vaccine, 31(30), 3059-3064. DOI Scopus12 WoS11 Europe PMC6
2013	Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., . . . Booy, R. (2013). Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537. DOI Scopus32 WoS28 Europe PMC21
2013	Braunack-Mayer, A., Tooher, R., Collins, J., Street, J., & Marshall, H. (2013). Understanding the school community's response to school closures during the H1N1 2009 influenza pandemic. BMC Public Health, 13(1), 1-15. DOI Scopus83 WoS68 Europe PMC43
2013	Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., & Baghurst, P. (2013). Parental perspectives of vaccine safety and experience of adverse events following immunisation. Vaccine, 31(16), 2067-2074. DOI Scopus30 WoS27 Europe PMC22
2013	Nissen, M., Marshall, H., Richmond, P., Jiang, Q., Harris, S., Jones, T., . . . Perez, J. (2013). A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatric Infectious Disease Journal, 32(4), 364-371. DOI Scopus49 WoS45 Europe PMC35
2013	Marshall, H., Richmond, P., Nissen, M., Wouters, A., Baber, J., Jiang, Q., . . . Perez, J. (2013). A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine, 31(12), 1569-1575. DOI Scopus63 WoS57 Europe PMC42
2013	Booy, R., Richmond, P., Nolan, T., McVernon, J., Marshall, H., Nissen, M., . . . Miller, J. (2013). Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlers. Pediatric Infectious Disease Journal, 32(2), 169-174. DOI Scopus7 WoS7 Europe PMC4
2013	Clarke, M., Rasiah, K., Copland, J., Watson, M., Koehler, A., Dowling, K., & Marshall, H. (2013). The pertussis epidemic: informing strategies for prevention of severe disease. Epidemiology and Infection, 141(3), 463-471. DOI Scopus12 WoS13 Europe PMC8
2012	Bryant, K., McVernon, J., Marchant, C., Nolan, T., Marshall, G., Richmond, P., . . . Miller, J. (2012). Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Human Vaccines & Immunotherapeutics, 8(8), 1036-1041. DOI Scopus9 WoS9 Europe PMC7
2012	Richmond, P., Marshall, H., Nissen, M., Jiang, Q., Jansen, K., Garces-Sanchez, M., . . . Perez, J. (2012). Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 12(8), 597-607. DOI Scopus114 WoS98 Europe PMC81
2012	Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., Watson, M., & Baghurst, P. (2012). Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Human Vaccines & Immunotherapeutics, 8(5), 662-667. DOI Scopus16 WoS13 Europe PMC10
2012	Kessels, S., Marshall, H., Watson, M., Braunack-Mayer, A., Reuzel, R., & Tooher, R. (2012). Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine, 30(24), 3546-3556. DOI Scopus305 WoS287 Europe PMC221
2012	Marshall, H., Tooher, R., Collins, J., Mensah, F., Braunack-Mayer, A., Street, J., & Ryan, P. (2012). Awareness, anxiety, compliance: Community perceptions and response to the threat and reality of an influenza pandemic. American Journal of Infection Control, 40(3), 270-272. DOI Scopus15 WoS13 Europe PMC12
2012	McVernon, J., Nolan, T., Richmond, P., Reynolds, G., Nissen, M., Lambert, S., . . . Rehm, C. (2012). A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers. Pediatric Infectious Disease Journal, 31(1), E15-E23. DOI Scopus13 WoS11 Europe PMC8
2012	Seale, H., Trung, L., Mackie, F., Kennedy, S., Boros, C., Marshall, H., . . . MacIntyre, C. (2012). A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine, 30(49), 7027-7031. DOI Scopus7 WoS6 Europe PMC5
2012	Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., . . . Booy, R. (2012). Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481. DOI Scopus53 WoS46 Europe PMC37
2012	Marshall, H., Richmond, P., Nissen, M., Jiang, Q., Anderson, A., Jansen, K., . . . Perez, J. (2012). Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial. Pediatric Infectious Disease Journal, 31(10), 1061-1068. DOI Scopus57 WoS52 Europe PMC41
2012	Khandaker, G., Rashid, H., Zurynski, Y., Richmond, P., Buttery, J., Marshall, H., . . . Booy, R. (2012). Nosocomial vs community-acquired pandemic influenza A (H1N1) 2009: a nested case-control study. Journal of Hospital Infection, 82(2), 94-100. DOI Scopus6 WoS7 Europe PMC5
2012	Richmond, P., Nissen, M., Marshall, H., Lambert, S., Roberton, D., Gruber, W., . . . Arora, A. (2012). A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine, 30(43), 6163-6174. DOI Scopus45 WoS46 Europe PMC39
2012	Clarke, M., & Marshall, H. (2012). Rotavirus vaccination for prevention of serious acute gastroenteritis and the importance of postlicensure safety monitoring. Journal of Infectious Diseases, 206(1), 3-5. DOI Scopus1 WoS1
2012	McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2012). Influenza vaccination during pregnancy: A systematic review of effectiveness and adverse effects. JBI Database of Systematic Reviews and Implementation Reports, 10(56 Suppl), S216-S226. DOI Scopus1
2011	Clarke, M., Davidson, G., Gold, M., & Marshall, H. (2011). Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 29(29-30), 4663-4667. DOI Scopus47 WoS47 Europe PMC28
2011	Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., . . . Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237. DOI Scopus15 WoS17 Europe PMC9
2011	Khandaker, G., Marshall, H., Peadon, E., Zurynski, Y., Burgner, D., Buttery, J., . . . Booy, R. (2011). Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood, 96(5), 453-456. DOI Scopus32 WoS33 Europe PMC21
2011	Booy, R., Richmond, P., Nolan, T., McVernon, J., Marshall, H., Nissen, M., . . . Boutriau, D. (2011). Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age. Pediatric Infectious Disease Journal, 30(4), 340-342. DOI Scopus10 WoS9 Europe PMC7
2011	Nolan, T., Richmond, P., Marshall, H., McVernon, J., Alexander, K., Mesaros, N., . . . Boutriau, D. (2011). Immunogenicity and safety of an investigational combined haemophilus influenzae Type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatric Infectious Disease Journal, 30(3), 190-196. DOI Scopus25 WoS23 Europe PMC20
2011	Buttery, J. P., Danchin, M. H., Lee, K. J., Carlin, J. B., McIntyre, P. B., Elliott, E. J., . . . Bines, J. E. (2011). Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. VACCINE, 29(16), 3061-3066. DOI WoS204 Europe PMC146
2010	Medina, D. M. R., Valencia, A., de Velasquez, A., Huang, L. -M., Prymula, R., Garcia-Sicilia, J., . . . Dubin, G. (2010). Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls. JOURNAL OF ADOLESCENT HEALTH, 46(5), 414-421. DOI WoS41 Europe PMC30
2010	Carbonell-Estrany, X., Simoes, E. A. F., Dagan, R., Hall, C. B., Harris, B., Hultquist, M., . . . Losonsky, G. A. (2010). Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. PEDIATRICS, 125(1), E35-E51. DOI WoS135 Europe PMC95
2010	White, O., Rowe, J., Richmond, P., Marshall, H., McIntyre, P., Wood, N., & Holt, P. (2010). Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine, 28(14), 2648-2652. DOI Scopus39 WoS36 Europe PMC31
2010	Marshall, H., Nolan, T., Diez-Domingo, J., Rombo, L., Sokal, E., Mares, J., . . . Jacquet, J. (2010). Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine, 28(27), 4411-4415. DOI Scopus12 WoS12 Europe PMC7
2010	Wood, N., McIntyre, P., Marshall, H., & Roberton, D. (2010). Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatric Infectious Disease Journal, 29(3), 209-215. DOI Scopus88 WoS78 Europe PMC54
2010	Nolan, T., McVernon, J., Skeljo, M., Richmond, P., Wadia, U., Lambert, S., . . . Greenberg, M. (2010). Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. Jama-journal of the American Medical Association, 303(1), 37-46. DOI Scopus174 WoS156 Europe PMC116
2010	Marshall, H., McIntyre, P., Roberton, D., Dinan, L., & Hardt, K. (2010). Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. International Journal of Infectious Diseases, 14(1), E41-E49. DOI Scopus3 WoS3 Europe PMC3
2009	Marshall, H., Ryan, P., Roberton, D., & Beilby, J. (2009). Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine. Journal of Paediatrics and Child Health, 45(5), 297-303. DOI Scopus15 WoS15 Europe PMC9
2009	Gibson, R., Barclay, D., Marshall, H., Moulin, J., Maire, J., & Makrides, M. (2009). Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. British Journal of Nutrition, 101(11), 1706-1713. DOI Scopus35 WoS36 Europe PMC23
2009	Marshall, H., Ryan, P., Roberton, D., Street, J., & Watson, M. (2009). Pandemic influenza and community preparedness. American Journal of Public Health, 99(SUPPL. 2), S365-S371. DOI Scopus34 WoS32 Europe PMC19
2009	de Benedictis, F. M., Franceschini, F., Hill, D., Naspitz, C., Simons, F. E. R., Wahn, U., . . . Vogel, M. (2009). The allergic sensitization in infants with atopic eczema from different countries. Allergy: European Journal of Allergy and Clinical Immunology, 64(2), 295-303. DOI Scopus91 Europe PMC53
2008	Marshall, H., Ryan, P., Roberton, D., Street, J., & Watson, M. (2008). Pandemic Influenza Preparedness: is the Community Really Prepared?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 12, E439. DOI
2008	Grüber, C., Warner, J., Hill, D., Bauchau, V., Warner, J. O., Naspitz, C. K., . . . Abeck, D. (2008). Early atopic disease and early childhood immunization - Is there a link?. Allergy: European Journal of Allergy and Clinical Immunology, 63(11), 1464-1472. DOI Scopus45 WoS34 Europe PMC20
2008	Hill, D. J., Hosking, C. S., de Benedictis, F. M., Oranje, A. P., Diepgen, T. L., Bauchau, V., & EPAAC Study Group. (2008). Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clinical & Experimental Allergy, 38(1), 161-168. DOI Scopus168 WoS146 Europe PMC86
2008	Nolan, T., Bernstein, D., Block, S., Hilty, M., Keyserling, H., Marchant, C., . . . Mendelman, P. (2008). Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with Measles-Mumps-Rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics, 121(3), 508-516. DOI Scopus38 WoS24 Europe PMC23
2008	Marshall, H. S., & Isaacs, D. (2008). "I want the one for older women" - Extending the human papillomavirus vaccine population base. Medical Journal of Australia, 189(9), 527. DOI
2007	Nolan, T., Lambert, S., Roberton, D., Marshall, H., Richmond, P., Streeton, C., . . . Boutriau, D. (2007). A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine, 25(51), 8487-8499. DOI Scopus48 WoS45 Europe PMC37
2007	Nolan, T., Lambert, S., Roberton, D., Marshall, H., Richmond, P., & Streeton, C. (2007). DTPa-HBV-IPV vaccine for primary vaccination of infants. Journal of Paediatrics and Child Health, 43(9), 587-592. DOI Scopus8 WoS8 Europe PMC4
2007	Marshall, H., Ryan, P., Roberton, D., & Baghurst, P. (2007). A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Australian and New Zealand Journal of Public Health, 31(3), 235-242. DOI Scopus85 WoS85 Europe PMC56
2006	Peadon, E., Burgner, D., Nissen, M., Buttery, J., Zurynski, Y., Elliott, E., . . . Booy, R. (2006). Case for varicella surveillance in Australia. Journal of Paediatrics and Child Health, 42(11), 663-664. DOI Scopus7 WoS2 Europe PMC5
2006	Hofman, T., Cranswick, N., Kuna, P., Boznanski, A., Latos, T., Gold, M., . . . Szalai, Z. (2006). Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Archives of Disease in Childhood, 91(11), 905-910. DOI Scopus28 WoS25 Europe PMC16
2006	Marshall, H., Gold, M., Gent, R., Quinn, P., Piotto, L., Clarke, M., & Roberton, D. (2006). Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children. Pediatrics, 118(4), 1501-1509. DOI Scopus21 WoS19 Europe PMC13
2006	Marshall, H., Nolan, T., Roberton, D., Richmond, P., Lambert, S., Jacquet, J., & Schuerman, L. (2006). A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years. Vaccine, 24(35-36), 6120-6128. DOI Scopus18 WoS13 Europe PMC10
2006	Jacquet, J., Begue, P., Grimprel, E., Reinert, P., Sandbu, S., Silfverdal, S., . . . Schuerman, L. (2006). Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A review. Vaccine, 24(13), 2440-2448. DOI Scopus23 WoS20 Europe PMC17
2005	Marshall, H., Ryan, P., & Roberton, D. (2005). Uptake of varicella vaccine - A cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine, 23(46-47), 5389-5397. DOI Scopus30 WoS31 Europe PMC20
2005	Roberton, D., Marshall, H., Nolan, T., Sokal, E., Diez-Domingo, J., Flodmark, C., . . . Stoffel, M. (2005). Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine, 23(43), 5099-5105. DOI Scopus12 WoS9 Europe PMC9
2004	Isaacs, D., Kilham, H., & Marshall, H. (2004). Should routine childhood immunizations be compulsory?. Journal of Paediatrics and Child Health, 40(7), 392-396. DOI Scopus19 WoS18 Europe PMC12
2004	Roberton, D., Marshall, H., Dinan, L., Boros, C., & Gold, M. (2004). Developmental immunology and vaccines: immune responses to vaccines in premature infants. Expert Review of Vaccines, 3(4), 343-347. DOI Scopus7 Europe PMC3
2004	Belshe, R., Newman, F., Anderson, E., Wright, P., Karron, R., Tollefson, S., . . . Tsai, T. (2004). Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. Journal of Infectious Diseases, 190(12), 2096-2103. DOI Scopus63 WoS49 Europe PMC39
2004	Belshe, R., Newman, F., Tsai, T., Karron, R., Reisinger, K., Roberton, D., . . . Anderson, E. (2004). Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. Journal of Infectious Diseases, 189(3), 462-470. DOI Scopus47 WoS37 Europe PMC28

Book Chapters

Year	Citation
2016	Street, J., Marshall, H., Braunack-Mayer, A., Rogers, W., Ryan, P., & The Fluviews Team. (2016). Seeking community views on allocation of scarce resources in a pandemic in Australia: Two methods, two answers. In S. Dodds, & R. Ankeny (Eds.), Big Picture Bioethics: Developing Democratic Policy in Contested Domains (Vol. 16, pp. 245-261). Switzerland: Springer. DOI

Conference Items

Year	Citation
2020	Rahaman, M., Milazzo, A., Marshall, H., Satter, S. M., Rahman, M., & Bi, P. (2020). Intra-country climate variability and geographical distribution of diarrhoea among children under five in Bangladesh. Poster session presented at the meeting of 32nd Annual Conference of the International Society for Environmental Epidemiology. Virtual.
2020	Rahaman, M., Milazzo, A., Marshall, H., Satter, S. M., Rahman, M., & Bi, P. (2020). Climatic factors and rotavirus infections among children under five years old in Bangladesh: time- series analysis. Poster session presented at the meeting of 32nd Annual Conference of the International Society for Environmental Epidemiology.
2019	M, R., A, M., H, M., & P, B. (2019). Livestock and its related occupations in spatial clustering of Q fever in South Australia, 2007-2017. Poster session presented at the meeting of Environmental Epidemiology. Ovid Technologies (Wolters Kluwer Health). DOI
2019	Rahaman, M. R., Milazzo, A., Marshall, H., Chaber, A. -L., & Bi, P. (2019). Q fever perceptions among South Australian animal science and veterinary students. Poster session presented at the meeting of Australian Public Health Conference 2019.
2019	Rahaman, M. R., Milazzo, A., Marshall, H., Crabb, D., & Bi, P. (2019). One Health perceptions of Q fever among South Australian livestock farmers. Poster session presented at the meeting of Communicable Diseases Control Conference 2019. Canberra.
2019	Rahaman, M. R., Milazzo, A., Marshall, H., Chaber, A. -L., & Bi, P. (2019). South Australian veterinary students’ One Health perspectives on Q fever prevention. Poster session presented at the meeting of Communicable Diseases Control Conference 2019. Canberra.
2019	McMillan, M., Walters, L., Koehler, A., Leong, L., Turra, M., Lawrence, A., . . . Marshall, H. (2019). 'B Part of It study’ Impact of 4CMenB vaccine on meningococcal carriage density in adolescents. Poster session presented at the meeting of 37th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). Ljubljana, Slovenia.
2018	McMillan, M., Walters, L., Turra, M., Lawrence, A., Sullivan, T., Leong, L., . . . Marshall, H. (2018). ‘B Part of It study’: Carriage of Neisseria meningitidis in first year university students in South Australia; a longitudinal study. Poster session presented at the meeting of 16th National Immunisation Conference. Adelaide.
2018	Strachan, R., Beggs, S., Fearon, D., Gilbert, G., Homaira, N., Lambert, S., . . . Jaffe, A. (2018). The impact of the 13 valent conjugate pneumococcal vaccine on pneumococcal serotypes causing childhood empyema in Australia. Poster session presented at the meeting of Abstracts of the The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting 2018, as published in Respirology. Adelaide, AUSTRALIA: Wiley. DOI
2015	Skinner, S., Davies, C., Cooper, S., Stoney, T., Marshall, H., Jones, J., . . . McGeechan, K. (2015). Randomised controlled trial of a complex intervention to improve school-based HPV vaccination for adolescents: the HPV. Edu study. Poster session presented at the meeting of Abstracts of the World STI & HIV Congress, as published in Sexually Transmitted Infection. Brisbane, AUSTRALIA: BMJ Publishing Group. DOI WoS4
2012	Tran, T., Clarke, M., & Marshall, H. (2012). Invasive pneumococcal disease: impact of pneumococcal vaccination in South Australian children. Poster session presented at the meeting of 15th International Congress on Infectious Diseases (ICID) Abstracts, as published in International Journal of Infectious Diseases. Bangkok, Thailand: Elsevier. DOI
2012	Marshall, H., Clarke, M., Liew, Y. Y., & Davidson, G. (2012). Severity of hospitalised rotavirus gastroenteritis in South Australian children prior to and following implementation of an infant rotavirus immunisation program. Poster session presented at the meeting of 15th International Congress on Infectious Diseases (ICID) Abstracts, as published in International Journal of Infectious Diseases. Bangkok, Thailand: Elsevier. DOI
2007	Makrides, M., Gibson, R., & Marshall, H. (2007). Effect of an infant formula supplemented with probiotics and long-chain polyunsaturated fatty acids (LCPUFA) on growth and immune markers of term infants: a randomised controlled trial. Poster session presented at the meeting of Abstracts European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Annual Meeting May 9–12, 2007 Barcelona, Spain, as published in Journal of Pediatric Gastroenterology and Nutrition. Barcelona, Spain: Lippincott, Williams & Wilkins. DOI

Theses

Year Citation

2014 McMillan, M. (2014). Influenza vaccination during pregnancy: a systematic review of effectiveness and safety.. (Master's Thesis).

Year	Citation
2014	McMillan, M. (2014). Influenza vaccination during pregnancy: a systematic review of effectiveness and safety.. (Master's Thesis).

Internet Publications

Year	Citation
2015	Mcmillan, M., Parrella, A., Clarke, M., & Marshall, H. (2015). A systematic review of the safety of diphtheria, tetanus, pertussis, and inactivated polio antigen containing vaccines administered during pregnancy. PROTOCOL.

Grant Funding

Category 1 – Total $17,004,013

National competitive Fellowship schemes

1.	2019-2023	CIA – NHMRC PF level 1 Optimising immunisation in vulnerable groups to improve health outcomes for disadvantaged children APP1155066	$498,000
2.	2015-2018	CIA – NHMRC CDF level 2 Immunisation practice and policy development in Australia: urgent priorities in prevention of infectious diseases in children, pregnant women and adolescents. APP1084951	$455,452
3.	2011-2014	CIA - NHMRC CDF level 1 Immunisation practice and policy development in Australia: responding to urgent priorities in prevention of endemic and epidemic infectious diseases in children. APP1016272	$384,160

National competitive schemes – NHMRC and MRFF

2022-2024	Ward J, Bradley C, Marshall H, Snelling T.
2022-2024	Bradley C, Ward J, Bickerstaffe A, Pearson O, Guy R, Griffiths K, Marshall H, Barzi F, Jacups Improving surveillance infrastructure for Indigenous primary health care	$1.99 million
2020-2021	Wood N, Richmond P, Marshall H MRFF Novel DNA based COVID-19 vaccine: A phase 1/1b trial for Australia	$2.9 million
2019-2023	Marshall H (CIA) B Part of it NT: Immunisation for adolescents against serious communicable diseases. NHMRC Partnership Grant APP1170965	$1,292,029
2019-2021	Lynn D, Marshall H (CIB). How does the microbiota modulate vaccine responses in human infants: A systems vaccinology approach. NHMRC Project Grant APP1156415	$858,033
2018-2022	Chang K, Binks M, O’Grady KA, Marshall H (CID), Toombs M, Smith-VaughanH Pizzutto S, Torzillo P, Grimwood K, Swamy G. Preventing early-onset pneumonia in Indigenous children through maternal immunisation: a multi-centre randomised controlled trial (RCT). NHMRC Project Grant APP1138555	$3,210,617
2016-2019	Macartney K, Leask J, Marshall H (CIC) et al Reducing vaccine preventable disease in children using national active hospital-based surveillance to evaluate and improve immunisation program performance. NHMRC Partnership Grant APP1113851	$1,049,915
2016-2018	Lynn D, Rogers G, Marshall H (CIC) et al.The impact of the neonatal gut microbiome on specific and nonspecific vaccine responses. NHMRC project APP1098429	$661,495
2014-2015	Marshall (AI) TESTOV - Pneumo - Evaluation of the effectiveness of the 13-valent pneumococcal conjugate vaccine against pneumococcal pneumonia in children NHMRC project grant.	$10,000
2012- 2016	Andrews R, Marshall H (CIF). FluMum: a prospective cohort study of mother-infant pairs assessing vaccination effectiveness against Influenza in Pregnancy. NHMRC project grant APP1020035	$2,481,065
2012-2014	Skinner R, Marshall H (CIE). A randomized controlled trial to assess the effectiveness of an educational intervention to improve HPV uptake through a school based immunization program. NHMRC project grant APP 1026765.	$723,634
2011-2013	Lan R, Gilbert G, Sintchenko V, McIntyre P, Marshall H (CIE), Wood N. Evolution of pertussis epidemics and effect of genotypes on infection outcomes and immunisation. NHMRC project grant APP1011942.	$638,100
2010-2012	Braunack-Mayer A, Marshall H, O’Keefe M, Burgess T, Skinner R, McCaffery K, Watson M. How can intersectoral collaboration between the health and education sectors be optimized? ARC Linkage Project LP100200007.	$275,000
2009- 2011	McIntyre P, Nolan T, Wood N, Marshall H (CID). Immunogenicity and safety of acellular pertussis vaccine at birth. NHMRC project grant APP0570756.	$1,200,000
2009-2010	Marshall H (CIA), Braunack-Mayer A, Ryan P, Street J. Evaluating community understanding of and participation in strategies to prevent the spread of H1N1. NHMRC H1N1 Influenza 09 APP0626867	$185,000
2009-2010	Elliott E, McIntyre P, Gold M, Marshall H, (CIF) Characterisation of H1N1 Influenza 09 in hospitalized children using Paediatric Active Enhanced Diseases Surveillance. NHMRC H1N1 Influenza 09 APP0633028.	$181,513

Category 2 - Total $555,790

2019	Marshall H, Fereday J, Tuckermand J, Sullivan T, Blyth C, Danchin M, Couper J, Tai A, Smith N. Utilising provider-parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial Women’s and Children’s Hospital Foundation	$100,000
2019	Clarke M, Marshall H, Lynn D. A clinical study to determine whether antibiotic-driven neonatal intestinal dysbiosis is associated with impaired vaccine responses. Women’s and Children’s Hospital Foundation	$100,000
2016	Marshall H A prospective pilot study investigating the impact of obesity on seroprotection following influenza vaccination in Australian children aged 11-17 years. Women’s and Children’s Hospital Foundation Departmental grant	$10,000
2015	Danchin M, Marshall H. Parent Immunisation needs and attitudes survey - Antenatal Clinics (PINA-A). Murdoch Children’s Research Institute	$12,000
2014-2015	Marshall H (CIA), Lambert S, Dodd J, Clarke M, Barr I, Gent R. Does obesity in pregnancy impact on immune response to influenza vaccines? Women’s and Children’s Hospital Foundation	$69,290
2014	Marshall H (CIA), Braunack-Mayer A, Ratcliffe J. Incorporating young people’s views into priority setting for preventative health strategies to improve the health of adolescents. Channel 7 Children’s Research Foundation	$74,500
2012-2012	Marshall H, Gold M. PAEDS surveillance: Pertussis. SA Health	$30,000
2012	Marshall H Faculty of Health Sciences grant, University of Adelaide	$15,000
2010- 2012	Marshall H Pertussis surveillance: use of a novel severity scoring system. SA Health	$30,000
2010- 2011	Marshall H, Thomas N. Are parents receiving the currently recommended vaccines to protect them and their newborn infant against pertussis? The Cocoon Study. SA Health	$56,000
2009-2010	Marshall H, Braunack-Mayer A, O’Keefe M. Human Papillomavirus vaccine; why are adolescents opting out? Faculty of Health Sciences new collaborations grant. University of Adelaide / SA Health.	$22,000
2008-2012	Boros C, Marshall H, Gold M. HPV Immunisation of children with immunosuppression. Arthritis Australia and SA Health.	$37,000

Category 3 - Total $15,097,877

	2019-2022	Marshall H. Evaluation of the South Australian MenB immunisation program. SA Health.
	2020	Marshall H. A Single-Site Study for the Collection of Pre- and Post- Vaccination Blood Samples From Volunteers Receiving the 2020 Southern Hemisphere Formulation of Inactivated Influenza Vaccine. bioCSL
	2019-2020	Marshall H. A phase 3, randomized, placebo controlled, double blind trial to evaluate the efficacy and safety of a prefusion F subunit respiratory syncytial virus (RSV) vaccine in infants born to vaccinated pregnant women C3671008 Pfizer
	2019	Marshall H. A Single-Site Study for the Collection of Pre- and Post- Vaccination Blood Samples From Volunteers Receiving the 2019 Southern Hemisphere Formulation of Inactivated Influenza Vaccine. bioCSL
	2018	Marshall H. A Single-Site Study for the Collection of Pre- and Post- Vaccination Blood Samples From Volunteers Receiving the 2018 Southern Hemisphere Formulation of Inactivated Influenza Vaccine. bioCSL
	2017-2019	Marshall H (CIA) et al. Meningococcal B vaccine carriage study. GlaxoSmithKline
	2017	Marshall H. A Single-Site Study for the Collection of Pre- and Post- Vaccination Blood Samples From Volunteers Receiving the 2017 Southern Hemisphere Formulation of Inactivated Influenza Vaccine. bioCSL
	2016	Marshall H. A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine with Aluminium in Healthy Third-trimester Pregnant Women; and safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in their Infants (RSV-M-301). Novavax
	2016	Marshall H. A Single Site Study for the Collection of Pre- and Post- Vaccination Blood Samples From Volunteers Receiving the 2016 Southern Hemisphere Formulation of Inactivated Influenza Vaccine. Seqirus/WHO influenza study 2016
	2016	Marshall H. Optimising protection for pregnant women and infants with maternal vaccination. Sanofi
	2016	Marshall H. A clinical study to determine whether antibiotic driven neonatal intestinal dysbiosis is associated with impaired vaccine responses. SAHMRI
	2015	Marshall H. Follow up of immunogenicity and safety of acellular pertussis vaccine given at birth to 4 years of age (Birth Pertussis Year 4 study). GlaxoSmithKline
	2015	Marshall H. A Single-Site Study for the Collection of Pre- and Post- Vaccination Blood Samples From Volunteers Receiving the 2015 Southern Hemisphere Formulation of Inactivated Influenza Vaccine. bioCSL
	2015	Marshall H. A phase 2, randomized, controlled, observer-blinded study conducted to describe the immunogenicity, safety, and tolerability of a neisseria meningitidis serogroup b bivalent recombinant lipoprotein 2086 vaccine (bivalent rlp2086) when administered to healthy toddlers aged 12 to <24 months Pfizer
	2015	Marshall H. A Phase 3, randomised, double blind, placebo-controlled study evaluating the efficacy and safety of a human monoclonal antibody, REGN2222, for the prevention of medically attended RSV infection in preterm infants. Regeneron.
	2015	Marshall H. A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dosing and Multiple Ascending Dosing in Infants Hospitalized with Respiratory Syncytial Virus (RSV) Infection. Alios
	2015	Marshall H. A Phase 3b, Open Label, Controlled, Multi-Center, Extension Study to Assess the Persistence of Bactericidal Activity at 4 to 7.5 Years After Two Dose Primary Series of Novartis Meningococcal B Recombinant Vaccine. Novartis
	2014-2018	Marshall H (CIA), Booy R, Barton B, Richmond P, Nissen M. Buttery J, Blythe C, N Crawford. The Long-term Impact of Serogroup B Invasive Meningococcal Disease (IMD) in Australian Adolescents and Young Adults. AMEND study. Pfizer
	2014	Marshall H. Immunogenicity and safety study of 1 and 2 doses of GSK Biologicals’ meningococcal vaccine GSK134612 in toddlers, persistence up to 5 years after vaccination and co-administration with Pfizer's pneumococcal vaccine Prevenar 13™ GlaxoSmithKline
	2014	Marshall H. VAXSMS: Evaluation of an App designed to encourage on-time immunisation of infants and young children. bioCSL
	2014	Marshall H. The vaccine response and long-term antibody persistence of GSK Biologicals’ MenACWY-TT vaccine administered as one dose at 6 years post-MenC primary vaccination in healthy subjects aged 12-18 months at primary vaccination GlaxoSmithKline
	2013	Marshall H. Identifying facilitators to high uptake of seasonal influenza vaccine and other recommended vaccines amongst Health care Workers (HCW) in different hospital wards in a tertiary paediatric hospital. GlaxoSmithKline
	2013	Marshall H. Incorporating young people’s views into priority setting for preventative health strategies to improve the health of adolescents. Channel7 Children’s Research Foundation
	2013	Marshall H. Severe influenza in children under five years of age – risk factors, complications and co-infections.
	2013-2014	Marshall H. Introduction of a meningitis B vaccine into primary healthcare - a survey of knowledge, attitudes and factors affecting immunisation practices among South Australian GPs (GP survey Men B). Royal Australian College of General Practitioners
	2013	Marshall H. A Phase III, Observer-Blind, Randomized, Controlled Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin®), in Healthy Children and Adolescents 4 to 17 Years of Age (V58_31). Novartis
	2012	Marshall H. Persistence of immunity and response to a booster dose of DTPa or dTpa vaccine at 18 months old following acellular pertussis vaccine given at birth in healthy infants (Birth Pertussis 18 month booster). GlaxoSmithKline
	2012-2013	Marshall H. A Phase 3, Randomized, Placebo and Active-Control, Observer-Blind Trial to Assess the Safety, Tolerability and Immunogenicity of a Meningococcal Serogroup B Recombinant Lipoprotein (rLP2086) Vaccine Given in Healthy Subjects Aged ≥11 to <26 Years. Pfizer.
	2012	Marshall H. Community knowledge and attitudes towards meningococcal disease and its prevention through introduction of new meningococcal vaccines; Health Monitor survey. Novartis.
	2012-2013	Marshall H. Impact of pneumococcal conjugate vaccine on severe pneumococcal disease requiring hospitalization in South Australian children. Pfizer.
	2011- 2012	Marshall H and VIRTU. Safety and immunogenicity of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine in children aged 6 – 35 months (Protocol:109825), GlaxoSmithKline.
	2011	Marshall H and VIRTU. A Phase III, Observer-Blind, Randomized, Multi-center Study to Evaluate the Safety,Tolerability, and Immunogenicity of Fluad and Agriflu Compared to the Non Adjuvanted Trivalent Influenza Vaccine Fluzone in Children 6 to <72 Months of Age Novartis, Sienna, Italy, BB-IND#14368
	2011-2012	Marshall H, Clarke M et al. A cross-sectional cohort study to assess the impact of the rotavirus vaccine introduction on severe gastroenteritis in South Australian children. Merck, USA.
	2011	Marshall H. A Phase 3, Randomized, Comparative, Multicenter Observer-Blind Study Evaluating the Safety and Immunogenicity of Novartis rMenB+OMV NZ Vaccine Formulated with OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years . Novartis.
	2011-2012	Marshall H, Thomas N. The impact of Invasive Meningococcal Disease in Australian Children (April 2000 – April 2011). Novartis.
	2010-2011	Marshall H, and VIRTU. A Phase 1 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Ascending Dose Levels of a 3-Antigen Staphylococcus aureus Vaccine (SA3Ag) in Healthy Adults (Protocol: 6123K1-1007-AU), Wyeth, USA.
	2009-2011	Marshall H, Rasiah K and VIRTU. A cross-sectional prospective observational study to determine the clinical severity of pertussis infection and epidemiological risk factors in Australian children admitted to hospital over a 12 month period. Sanofi-Pasteur.
	2009-2010	Marshall H, Boros C, Rasiah K and VIRTU. A phase 2, multicentre, randomised, observer-blind, study to evaluate the immunogenicity, safety and tolerability of CSL’s 2009 H1N1 Influenza Vaccine (CSL425) in healthy children aged ³ 6 months to < 9 years. (Protocol No. CSLCT-CAL-09-60), CSL,Melbourne, Australia.
	2009-2010	Marshall H and VIRTU. A randomized, single-blind, placebo-controlled, phase 2 trial of the safety, immunogenicity and tolerability of meningococcal serogroup B (MnB) rLP2086 vaccine at doses of 60 ug, 120 ug and 200ug in healthy adolescents aged 11 to 18 years (Protocol No. 6108A1-2001-WW), Wyeth, USA.
	2009-2010	Marshall H and VIRTU. A phase 1/2a, randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability, immunogenicity and vaccine-like viral shedding of MEDI-534, a live, attenuated intranasal vaccine against respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3), in healthy 6 to < 24 month-old children and in 2 month-old infants MedImmune, USA.
	2009-2010	Russell F, Marshall H, Druavesi P, Mulholland K, Jenkins K, Bingwar F, Samuela J, Ravea S, Volavola S, LaVincente S, Meilnik D. Evaluation of Human Papillomavirus (HPV) vaccine campaign in Fiji. Merck, USA.

Teaching/Mentoring

2018-current Biology of Childhood Growth, Development & Health

2018-current Infant, Child & Adolescent Health

2008-2012 Poster Assessor, Research Expo 2008, University of Adelaide, 22^nd July 2008

2007-current Lecturer, Health Sciences Honours students, Discipline of Paediatrics

2006-2007 Examiner 5^th year medical students OSCI exams, University of Adelaide

2005-current Lecturer, Public Health Science students, Discipline of Public Health

2005-current Co-ordinator of VIRTU Seminars

2005-2006 Co-ordinator of Allergy, Immunology, Rheumatology and Vaccinology program

2003-2006 Lecturer, 4^th year Medical Students, Discipline of Paediatrics

2003-current Lecturer, Diploma in Child Health, Discipline of Paediatrics

1999-current Oral Assessor for entry into medicine/dentistry

1997-1999 Tutor in General Paediatrics – medical student teaching, years 2-5

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2017	Principal Supervisor	Assessing the impact of obesity and antibiotics on maternal and infant vaccine responses	Doctor of Philosophy	Doctorate	Part Time	Mrs Michelle Clarke

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2019 - 2021	Co-Supervisor	The One Health Approach to Q Fever Prevention and Control in South Australia	Doctor of Philosophy	Doctorate	Full Time	Mr Md Rezanur Rahaman
2017 - 2021	Principal Supervisor	Pertussis and Influenza Vaccination during Pregnancy: Maternal and Neonatal Health Outcomes	Doctor of Philosophy	Doctorate	Full Time	Mr Hassen Ibrahim Mohammed
2017 - 2021	Principal Supervisor	Impact of meningococcal vaccines on carriage and disease	Doctor of Philosophy	Doctorate	Full Time	Mr Mark McMillan
2016 - 2019	Principal Supervisor	GBS STUDY: Assessing Disease Burden and Risk Factors for Neonatal Group B Streptococcal Infection to Inform the Best Strategies to Prevent Life Threatening Infections in Newborns	Master of Philosophy (Clinical Science)	Master	Full Time	Dr Marianne Yanni
2015 - 2020	Principal Supervisor	Influenza Vaccination in Children with Special Risk Medical Conditions	Doctor of Philosophy	Doctorate	Full Time	Ms Jane Louisa Tuckerman
2014 - 2019	Principal Supervisor	Improving Adolescent Health Through Immunisation: A Case Study - Invasive Meningococcal Disease	Doctor of Philosophy	Doctorate	Full Time	Dr Bing Wang
2012 - 2014	Co-Supervisor	Influenza vaccination during pregnancy: A systematic review of effectiveness and safety	Master of Clinical Science	Master	Full Time	Mr Mark McMillan
2012 - 2014	Principal Supervisor	Clinical outcomes, costs, knowledge and awareness of invasive meningococcal disease (IMD) in South Australia	Master of Philosophy (Public Health)	Master	Full Time	Dr Bing Wang
2012 - 2016	Principal Supervisor	Determinants of Severe Pertussis Infection in Australian Children and Awareness and Uptake of Pertussis Vaccination in Adults	Master of Philosophy (Public Health)	Master	Part Time	Mrs Michelle Clarke
2011 - 2014	Co-Supervisor	Postmarketing Vaccine Safety Passive Surveillance: An exploratory study of parent and healthcare provider reporting of Adverse Events Following Immunisation (AEFI)	Doctor of Philosophy	Doctorate	Full Time	Dr Adriana Parrella

Committee Memberships

Date	Role	Committee	Institution	Country
2020 - ongoing	Member	COVID19 Technical Advice and Response Committee	Public Health Association of Australia	Australia
2019 - ongoing	Member	Vaccine evaluation: Health Technology Assessment Research Support and Other services	National Program Vaccines Evaluation, Australian Government	Australia
2019 - ongoing	Chair	Health Consumers Engagement Committee, Robinson Research Institute	University of Adelaide	Australia
2018 - ongoing	Member	South Australian Immunisation Strategic Committee	SA Health	Australia
2016 - ongoing	Member	South Australian Public Health Council	Government of South Australia	Australia
2016 - ongoing	Member	Faculty of Health Sciences Research Committee	University of Adelaide	Australia
2014 - ongoing	Member	Scientific Committee	Public Health Association of Australia Immunisation Conference	Australia
2014 - 2018	Member	Gender Equity and Diversity Working Group	University of Adelaide	Australia
2014 - ongoing	Member	Australian Influenza Vaccine Committee	Therapeutic Goods Administration, Australian Government	Australia
2013 - ongoing	Member	Robinson Research Institute Executive Committee	University of Adelaide	Australia
2012 - ongoing	Member	National Centre for Immunisation Research and Surveillance Scientific Advisory Committee	Kids Research Institute, Children’s Hospital at Westmead	Australia
2010 - ongoing	Member	Pertussis Response Strategic Working Party	SA Health	Australia
2010 - ongoing	Member	School of Paediatrics and Reproductive Health Research Committee	University of Adelaide	Australia
2010 - ongoing	Member	School of Paediatrics and Reproductive Health Honours Committee	University of Adelaide	Australia

Review, Assessment, Editorial and Advice

Date	Title	Type	Institution	Country
2020 - ongoing	Assessor, COVID-19 New Zealand Rapid Response Research	Grant Assessment	Health Research Council of New Zealand	New Zealand
2020 - 2020	Assessor, MRFF – 2020 Antiviral Development for COVID-19	Grant Assessment	National Health and Medical Research Council	Australia
2020 - ongoing	Member, COVID-19 Maternal Immunization Working Group, COVAX ACT Accelerator vaccine pillar	Advice	Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO
2020 - 2020	Rapid Research Information Forum report of the most promising vaccines for COVID-19.	Peer Review	Australian Govenment	Australia
2020 - ongoing	Invited Member, COVID-19 Vaccination Implementation Working Group	Advice	SA Health	Australia
2019 - ongoing	Member, Safety Platform for Emergency vACcines (SPEAC)	Advice	CEPI and Brighton Collaboration
2013 - 2018	Development Grant Review Panel - Scientific Assessor	Grant Assessment	NHMRC	Australia
2012 - 2012	Deputy Chair, Grants Review Panel, Paediatrics and Reproductive Health	Grant Assessment	NHMRC	Australia
2012 - 2012	Centres of Research Excellence - Population Health Peer Review Panel (Invited)	Grant Assessment	NHMRC	Australia
2011 - 2011	Deputy Chair (Invited), Grants Review Panel, Immunology	Grant Assessment	NHMRC	Australia

Position: Affiliate Lecturer, Medical Director VIRTU & A-Prof Vaccinology
Phone: 81618115
Email: helen.marshall@adelaide.edu.au
Fax: 83136885, 81617031
Campus: Womens & Childrens Hospital
Building: WCH - Good Friday Building,WCH - Clarence Rieger Building, floor 2
Org Unit: Public Health, Women's and Children's Health